Oncological and functional outcomes of cytoreductive robot-assisted radical prostatectomy integrated with ADT-based therapy in node-positive and low-volume metastatic prostate cancer

The prognostic significance of undetectable PSA nadir in metastatic hormone-sensitive prostate cancer

Objective sarcopenia predicts long-term treatment decision regret in disease-free prostate cancer survivors

Sarcopenia, frailty, and systemic inflammation in mCRPC patients: Explaining the paradox between biochemical response and overall survival

Luteolin suppresses high-fat diet-induced rat prostate carcinogenesis with reduced proliferative activity

Balancing survival and quality of life: Optimizing treatment for locally and regionally advanced prostate cancer

Neuroprotective potential of tadalafil against docetaxel-induced peripheral neuropathy in prostate cancer

Incidence, risk factors, and clinical outcomes of cutaneous adverse events in prostate cancer patients treated with apalutamide